GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pure Biologics SA (WAR:PUR) » Definitions » Net Margin %

Pure Biologics (WAR:PUR) Net Margin % : -165,666.67% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Pure Biologics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Pure Biologics's Net Income for the three months ended in Mar. 2024 was zł-4.97 Mil. Pure Biologics's Revenue for the three months ended in Mar. 2024 was zł0.00 Mil. Therefore, Pure Biologics's net margin for the quarter that ended in Mar. 2024 was -165,666.67%.

The historical rank and industry rank for Pure Biologics's Net Margin % or its related term are showing as below:

WAR:PUR' s Net Margin % Range Over the Past 10 Years
Min: -48724.64   Med: -1145.72   Max: -7.23
Current: -48724.64


WAR:PUR's Net Margin % is ranked worse than
96.59% of 1027 companies
in the Biotechnology industry
Industry Median: -151.78 vs WAR:PUR: -48724.64

Pure Biologics Net Margin % Historical Data

The historical data trend for Pure Biologics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Biologics Net Margin % Chart

Pure Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -236.20 -2,055.24 -4,631.89 -3,867.52 -37,572.63

Pure Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24,289.66 -991,500.00 -13,566.07 -123,755.56 -165,666.67

Competitive Comparison of Pure Biologics's Net Margin %

For the Biotechnology subindustry, Pure Biologics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pure Biologics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pure Biologics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Pure Biologics's Net Margin % falls into.



Pure Biologics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Pure Biologics's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-35.694/0.095
=-37,572.63 %

Pure Biologics's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-4.97/0.003
=-165,666.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pure Biologics  (WAR:PUR) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Pure Biologics Net Margin % Related Terms

Thank you for viewing the detailed overview of Pure Biologics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pure Biologics (WAR:PUR) Business Description

Traded in Other Exchanges
Address
ul. Dunska 11, Wroclaw, POL, 54-427
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.

Pure Biologics (WAR:PUR) Headlines

No Headlines